Teva reports positive data from Phase III pediatric migraine prevention trial

Teva reports positive data from Phase III pediatric migraine prevention trial

Submitted by admin on July 19, 2024 - 11:42am
Source: 
Clinical Trials Arena
News Tags: 
Teva Pharmaceutical
pediatrics
migraines
Ajovy
clinical trials
Headline: 
Teva reports positive data from Phase III pediatric migraine prevention trial
snippet: 

Teva Pharmaceutical has reported positive data from the Phase III SPACE clinical trial of AJOVY (fremanezumab) in preventing episodic migraines in children and adolescent patients aged six to 17 years.

Do Not Allow Advertisers to Use My Personal information